000 | 01214 a2200337 4500 | ||
---|---|---|---|
005 | 20250514050316.0 | ||
264 | 0 | _c20021108 | |
008 | 200211s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1086/342325 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaly, P | |
245 | 0 | 0 |
_aReply to Dr. Charlebois et Al. (Clin infect dis 2002; 34:425-33). _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cNov 2002 |
||
300 |
_a1135 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aCanada _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLife Expectancy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aSerotyping |
650 | 0 | 4 |
_aStaphylococcal Infections _xepidemiology |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
700 | 1 | _aBryce, E A | |
700 | 1 | _aBuxton, J | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 35 _gno. 9 _gp. 1135 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/342325 _zAvailable from publisher's website |
999 |
_c12194083 _d12194083 |